All patients were administered intranasal budesonide for 12 months. Patients were evaluated for nasal symptoms, polyp size and quality of life. At 6 and 12 months, a significant improvement in all ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

His medication list included albuterol, budesonide-formoterol inhaler, fluticasone nasal spray, montelukast, tiotropium bromide inhaler, and loratadine daily." ...